Nothing Special   »   [go: up one dir, main page]

Bartell et al., 1963 - Google Patents

The in vivo interaction between staphylococcus bacteriophage and Staphylococcus aureus

Bartell et al., 1963

View PDF
Document ID
11493643184921319403
Author
Bartell P
Thind I
Orr T
Blakemore W
Publication year
Publication venue
The Journal of Experimental Medicine

External Links

Snippet

Staphylococcus bacteriophage 81 is capable of in vivo interaction with Staphylococcus aureus, Type 80/81. This is immediately made evident by increased levels of bacteriophage and concomitant survival of 81 per cent infected mice. The reaction is dependent upon the …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Bacteriophages
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Similar Documents

Publication Publication Date Title
Koenig Factors Relating to the Virulence of Staphylococci: I. Comparative Studies on Two Colonial Variants
Mchugh et al. Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin: A new threat in burn units?
Dubos et al. The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dysenteriae
CN101835384B (en) Anti-bacteria compositions
Kumari et al. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae
Jones et al. Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin.
US3192116A (en) Anti-tumor clostridium composition
Horowitz et al. Endocarditis associated with Comamonas acidovorans
Schaffner et al. Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
Carrero et al. Report of six cases of human infection by Serratia plymuthica
Morrison Jr et al. Community-acquired bloodstream infection caused by Pseudomonas paucimobilis: case report and review of the literature
Conti et al. Studies on the pathogenesis of staphylococcal infection: IV. The effect of bacterial endotoxin
Bartell et al. The in vivo interaction between staphylococcus bacteriophage and Staphylococcus aureus
Burgess et al. Failure of cephaloridine in a case of staphylococcal endocarditis.
Rowley Antibacterial systems of serum in relation to nonspecific immunity to infection
Ward Protective action of VI bacteriophage in Eberthella typhi Infections in mice
Muschel et al. Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin
Cary et al. Slide agglutination technique for the rapid differentiation of Mima polymorpha and Herellea from the Neisseriae
Lam et al. ABSCESS-FORMING FACTOR (S) PRODUCED BY STAPHYLOCOCCUS AUREUS II: Abscess Formation and Immunity by a Staphylococcus and Its Mutants
Sanders et al. Prevention of meningococcal infections
Compton Sensitization and immunization with bacteriophage in experimental plague
Noyes et al. The detection of bacterial endotoxins in the plasma of dogs with experimental peritonitis
Fisher Experimental Staphylococcal Infection of the Subcutaneous Tissue of the Mouse: II. Promotion of the Infection with Staphylococcal Cells and Products
Walker et al. Chemotherapy of an experimental Bacteroides fragilis infection in mice
Tenney et al. Comparative evaluation of supplemented peptone broth with sodium polyanetholesulfonate and Trypticase soy broth with sodium amylosulfate for detection of septicemia